NDC to RxNorm Crosswalk 54092-468 Mydayis

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 54092-468 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Mydayis . The unique RxCUI concepts linked to this product are: 1927610, 1927616, 1927617, 1927619, 1927630, 1927632, 1927637 and 1927639. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1927610

Concept: amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927616

Concept: Mydayis 50 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG Extended Release Oral Capsule [Mydayis]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Mydayis 50 MG 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927617

Concept: amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927619

Concept: Mydayis 25 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG Extended Release Oral Capsule [Mydayis]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Mydayis 25 MG 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927630

Concept: amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927632

Concept: Mydayis 12.5 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG Extended Release Oral Capsule [Mydayis]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Mydayis 12.5 MG 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927637

Concept: amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG Extended Release Oral Capsule
Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form
Concept: amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG 3-Bead 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1927639

Concept: Mydayis 37.5 MG 24HR Extended Release Oral Capsule
Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Concept: 3-Bead 24 HR amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG Extended Release Oral Capsule [Mydayis]
Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
Concept: Mydayis 37.5 MG 24HR Extended Release Oral Capsule
Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.


What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.